Key Takeaways
- Order book crosses ₹1,000 crores for the first time: The milestone reflects improving demand across pharma and specialty chemicals, with competitive intensity easing and margins improving month after month.
- Recovery is sequential, not yet complete: All three segments improved QoQ, but reported revenue was held back by customer delivery acceptance delays tied to geopolitical uncertainty, a pattern that persisted from Q1 into Q2.
- THALETEC adoption is gaining traction in India: The premium glass-lined product line contributed 22% of India GLE revenue in Q2, and management expects wider customer acceptance to drive further mix improvement and margin uplift.[12-13]
- Omeras turned EBITDA-positive in H1, with a landmark tunnel order in hand: The EUR 2.06 crore Fehmarnbelt tunnel win provides 3+ years of revenue visibility, and the renamed HLE Surface Technologies unit is now staffed with a new COO, CFO, and sales team to drive the ramp-up.
- What to watch next quarter: Whether the ₹1,000+ crore order book converts into dispatched revenue in H2 as promised, the pace of margin expansion toward the 15% FY28 target, and commissioning of the Omeras India plant.
The Order Book Milestone & What It Means
- Record consolidated order book: Crossed ₹1,000 crores for the first time in company history, driven by strong order accretion reflecting customer confidence in engineering capabilities and execution track record across domestic and international markets.
- Demand drivers: Inquiries across pharmaceutical and specialty chemical industries improved, with several previously deferred projects now progressing toward finalization; India API and specialty chemical demand is "quite high," U.S. demand is "quite high," while Europe remains slightly subdued.
- Competitive intensity easing: Earlier price pressure was driven by equipment manufacturers trying to fill capacity; now that market demand has picked up, HLE is booking orders at improving margins month after month.
- Order book composition: Excluding the Fehmarnbelt tunnel order, the current book contains no single outsized order comparable to the earlier large Kinam order; it is all regular, repeating, sustainable business with a mix of project orders of different sizes.
- Conversion priority: Key H2 priorities are converting the record order book into timely project execution, improving margins through favorable product mix, trending cost efficiencies, and expanding product portfolio and customer relationships.
Patel: "Q2 FY27 has been a significant milestone for HLE Glascoat with our consolidated order book crossing the INR1,000 crores mark for the first time in the company's history."
The Revenue Recognition Problem
- Revenue is booked only on dispatch, not on order or manufacture: The execution cycle runs 4 to 7 months from order to dispatch, meaning revenue and profit reflection lags order flow by a couple of quarters.
- Delivery acceptance delays are a recurring drag: Q1 and Q2 results were marginally impacted because customer delivery acceptances get postponed due to geopolitical disturbances, delaying customer project execution by a month or two; products are manufactured and kept ready as per order but not dispatched because the customer is not ready.
- The H2 bet: Management expects Q3 and Q4 performance to be better, especially given the order book and business visibility; the order book will be executed predominantly during Q3 and Q4, with better industry response visible in those quarters.
Ganjwala: "We only account for revenues only when the equipment has been dispatched to the customer."
Ganjwala: "We might have a situation and we do have a situation where products are manufactured and kept ready as per order, but are not dispatched because the customer is not ready."
THALETEC: The Premium Mix Shift
- India adoption accelerating: THALETEC products contributed approximately 22% of overall glass-lined product business in India during Q2, reflecting a transition gaining momentum as wider customer adoption requires gradual shift in market preferences.
- Premium positioning pays off when demand is high: HLE has placed THALETEC as a premium offering in the Indian market; positioning premium products is easier when demand is higher, and moving from commoditized products to specialized THALETEC products means better realizations and better margins.[12-13]
- International strength: THALETEC business continues to strengthen presence in international markets, particularly across the U.S. and Europe, supported by growing customer engagement and increasing opportunities in pharmaceutical and specialty chemical industries.
- Revenue trajectory: H1 FY27 revenue of ₹192 crores versus FY26 full-year ₹343 crores; on a pro rata basis this represents almost a 12% to 13% increase, per management.
- Margin mechanics: GLE in India is a high gross margin business with high fixed costs; once a certain threshold is crossed, the flow of profits and contribution to the bottom line is quite substantial.
- Europe cost advantage: Both THALETEC and Omeras are well equipped to handle European cost pressures because of a well-established manufacturing base in India; end users in chemical and pharma industries are now exploring options to make capex more efficient, though management sees no scenario where European plants are emptied and everything is sourced from low-cost countries.
Patel: "We don't see at least in the medium-term, a scenario where the European manufacturing plants will be empty and everything will be sourced from India or another low-cost country."
Omeras (HLE Surface Technologies): Breakeven Achieved, Ramp-Up Underway
- EBITDA breakeven in H1 FY27: Omeras achieved turnover in excess of EUR 0.85 crore in H1 and touched EBITDA breakeven; PBT remains marginally in loss due to interest and depreciation. Q4 FY26 actually incurred a loss, correcting an analyst assumption that breakeven was achieved earlier.
- Landmark tunnel order: A EUR 2.06 crore order secured for vitreous enamel cladding panels for the Fehmarnbelt tunnel connecting Germany and Denmark; supply starts early-to-mid next year with delivery over 3 to 3.5 years, providing long-term revenue visibility.
- Organizational rebuild: Significant capability enhancement: new Chief Operations Officer from a large American multinational, new CFO on board, enhanced design team, new sales team members across various European geographies.
- Market opportunity: Enameled panels serve both infrastructure projects (metro stations, tunnels, where Omeras has a strong multi-decade track record) and architectural projects, a new area where architects in Western markets are showing large interest.
- Margin structure advantage: Higher gross margins mean once breakeven is crossed, profitability increase is likely to be relatively quicker than similar businesses because gross margin will flow down to the bottom line.
- India plant: Omeras India business is likely to get commissioned in the next two quarters or so.
Kinam & the Heavy Engineering Bet
- Traditional business growing: Kinam's traditional business covering chemicals, paints, and APIs is growing reasonably.
- Oil and gas entry via track record: Last year's large order was a breakthrough into the oil and gas segment and will be the basis of track record creation for becoming a Tier 1 vendor to these industries.
- Lumpy initially: The first one or two orders will be spread out and may not come one immediately after the other; after that, multiple orders can flow and execution will happen in parallel, becoming a continuing ongoing business. Management estimates roughly 12 to 18 months away from that scenario.
- New heavy engineering plant: A new plant at Adas, near Anand, focused on heavy equipment in excess of 100–150 tons, large diameters up to 4.5–5 meters, length 15–20 meters; applications in energy, oil and gas, petrochemicals, and renewable energy; USP is the ability to handle large and complex jobs in various materials.
- Heavy engineering economics: Initial-period EBITDA margins of 15% to 18%; mature basis close to about 22%. Peak revenue has no ceiling and depends on capacity and capability; comparable companies have done well in excess of ₹1,500 crores or ₹2,000 crores solely in this business.
Ganjwala: "That will now be the basis of a track record creation for the future... that track record will actually be of great and immense use to us in going forward to becoming like a Tier 1 vendor to some of these industries."
Ganjwala: "I don't think that the peak is only what you bring upon yourself. There is really no ceiling. This is a very big market. It all depends on capacity and capability."
Margins & Financial Health
- Consolidated EBITDA margins already at 11% in Q2: Management expects this to get better and stands by the previously stated 15% EBITDA margin target, noting it is "very much on track" and hopeful of achieving it "probably earlier rather than later."
- India GLE margin trajectory: Third and fourth quarter performance expected to be better given the order book and business visibility; FY27 India GLE revenue expected between ₹260 crores and ₹280 crores.
- Working capital stretched: Net working capital days increased to 102 days from 80 days in FY26, in line with order book expansion; going forward, focus on improving efficiency through better inventory management, disciplined receivables collection, and optimizing the cash conversion cycle.
- Debt manageable: Debt on an overall basis is very manageable and not an area of concern; management would like to build for a rainy day going forward.
- Capital allocation stance: Management is driven by consolidation at this point; all businesses look promising. If a strategic opportunity arises in and around the core area of expertise, of a size and scale that can be digested, management would look at it, but the current feeling is to build on existing businesses and consolidate.
Ganjwala: "To be very honest, 15% is not an improvement. It is something that we've historically achieved and we are just getting back to those numbers."
Ganjwala: "I think the management is driven by consolidation at this point of time. All our businesses are looking promising and encouraging."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Order book conversion | Record ₹1,000+ crore order book executed predominantly in H2 | Q3 and Q4 FY27 |
| India GLE revenue | ₹260–280 crores for FY27 | FY27 |
| Consolidated revenue target | ₹2,000 crores, driven by existing products, new products, and Omeras India plant | FY28 |
| Consolidated EBITDA margin | 15%, "very much on track," hopeful of achieving earlier | FY28 |
| Heavy engineering initial EBITDA margin | 15% to 18% | Initial periods of operation |
| Heavy engineering mature EBITDA margin | Close to 22% | Mature basis |
| Omeras India plant commissioning | Likely to get commissioned | Next 2 quarters or so |
| Fehmarnbelt tunnel order delivery | Supply starts early-to-mid next year, delivery over 3 to 3.5 years | Starting FY28 |
| Kinam oil & gas recurring business | Multiple parallel orders becoming a continuing ongoing business | Roughly 12 to 18 months away |
| Post-FY28 organic growth | 15–18% ordinary growth, heavy engineering adding another 5–7% on top | Post-FY28 |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Consolidated revenue from operations | ₹346.7 cr, +15.3% QoQ |
| H1 FY27 consolidated revenue | ₹647.4 cr, +2% YoY |
| EBITDA | ₹39 cr, margin 11.2%; +72.3% QoQ |
| H1 FY27 EBITDA | ₹61.6 cr, margin 9.5%; -23% YoY |
| PAT | ~₹16 cr, margin 4.6%; +680% QoQ |
| Consolidated order book | ₹1,087.3 cr, +51% YoY and +64% QoQ |
| Order book accretion during Q2 | ~₹425 cr |
| Total new orders during Q2 | ~₹775 cr, including EUR 2.1 cr Omeras order |
| Glass lined products revenue | ₹195.4 cr, +24.2% YoY |
| Filtration, drying and other equipment revenue | ₹102 cr, +5.4% QoQ |
| Heat exchanger equipment revenue | ₹48.8 cr, -12.3% YoY and +362.3% QoQ |
| THALETEC contribution to India glass lined business | 22% of overall glass lined product business in India |
| THALETEC Germany H1 FY27 revenue | ~₹192 cr, EBITDA margin a little over 11.5% |
| Omeras H1 FY27 turnover | a little in excess of EUR 0.85 cr, achieved EBITDA breakeven |
| Net working capital days | 102 days, up from 80 days in FY26 |